MALVERN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life ...
It’s well-known that women are more likely to suffer from depression than men. A new study has now revealed that the genetic ...
Closed-loop targeted deep brain stimulation holds promise in addressing symptoms of depression and obsessive-compulsive ...
GH Research ( (GHRS) ) has issued an update. GH Research PLC announced its participation in the 38th European College of Neuropsychopharmacology Congress held from October 11-14, 2025, in Amsterdam.
Newspoint on MSN
YouTube Update: YouTube launches mental health and wellbeing section for teens, featuring special content..
YouTube is launching a new mental health and wellbeing video section for teens. This section will feature curated content on ...
6d
GH Research Announces Novel Therapies Symposium Presentation and Posters at the 2025 ECNP Congress
GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in depression, today announced ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback